NCR3 and neoplasm: Stress-induced ligands, such as ULBP1, CD155, and CD112, are frequently upregulated in tumor cells and are recognized by NK cell receptors like NKG2D, NKp30, and NKp44, thereby providing an additional anti-tumor mechanism [81].